S16: Endolysosomal and lipid metabolism dysfunction in Parkinson’s - from dysfunction to therapeutics

S16: Endolysosomal and lipid metabolism dysfunction in Parkinson’s - from dysfunction to therapeutics

Tuesday, April 29, 2025 9:30 AM to 11:15 AM · 1 hr. 45 min. (Europe/London)
Symposium

Information

Convened by Parkinson's UK

  • Dr Emil Gustavsson - Understanding transcript diversity and its impact on endolysosomal function in Parkinson’s Disease
  • Chair: Dr Esther Sammler - Impact of LRRK2 gene mutations on endolysosomal function
  • Chair: Professor Tony Shapira - Therapeutic approaches targeting the lysosomal enzyme glucocerebrosidase
  • Dr Saranna Fanning - Lipid metabolism as a therapeutic target for Parkinson’s
Theme
Ageing & neurodegeneration

Log in